UY32458A - NEW HETEROCICLICAL COMPOUNDS - Google Patents

NEW HETEROCICLICAL COMPOUNDS

Info

Publication number
UY32458A
UY32458A UY0001032458A UY32458A UY32458A UY 32458 A UY32458 A UY 32458A UY 0001032458 A UY0001032458 A UY 0001032458A UY 32458 A UY32458 A UY 32458A UY 32458 A UY32458 A UY 32458A
Authority
UY
Uruguay
Prior art keywords
pyridone
new
derivative
salts
pharmaceutical compositions
Prior art date
Application number
UY0001032458A
Other languages
Spanish (es)
Inventor
Jose Maria Bueno Calderon
Jose Maria Fiandor-Roman
Margarita Puente Felipe
Jesus Chicharro Gonzalo
Snthil Kuma Kusalakumari Sukumar
Maleki Mehran
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of UY32458A publication Critical patent/UY32458A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un derivado de 4-piridona (4-piridona) de la Fórmula I y sales farmacéuticamente aceptables del mismo, formas cristalina de dicho derivado de 4-piridona y sales de las mismas, composiciones farmacéuticas que comprenden dicho derivado de 4 piridona y sales de los mismos y el uso de las composiciones farmacéuticas en la quimioterapia de ciertas infecciones parasitarias tales como la malaria, y en particular la infección por Plasmodium falciparum.A 4-pyridone (4-pyridone) derivative of Formula I and pharmaceutically acceptable salts thereof, crystalline forms of said 4-pyridone derivative and salts thereof, pharmaceutical compositions comprising said 4-pyridone derivative and salts thereof. themselves and the use of pharmaceutical compositions in the chemotherapy of certain parasitic infections such as malaria, and in particular Plasmodium falciparum infection.

UY0001032458A 2009-02-20 2010-02-18 NEW HETEROCICLICAL COMPOUNDS UY32458A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09382023 2009-02-20
US18699009P 2009-06-15 2009-06-15
US25967809P 2009-11-10 2009-11-10

Publications (1)

Publication Number Publication Date
UY32458A true UY32458A (en) 2010-08-31

Family

ID=40578503

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032458A UY32458A (en) 2009-02-20 2010-02-18 NEW HETEROCICLICAL COMPOUNDS

Country Status (4)

Country Link
AR (1) AR075522A1 (en)
TW (1) TW201039834A (en)
UY (1) UY32458A (en)
WO (1) WO2010094738A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9005518D0 (en) 1990-03-12 1990-05-09 Wellcome Found Heterocyclic compounds
EA200870545A1 (en) 2006-05-31 2009-12-30 Глэксо Груп Лимитед NEW HETEROCYCLIC COMPOUNDS

Also Published As

Publication number Publication date
TW201039834A (en) 2010-11-16
AR075522A1 (en) 2011-04-06
WO2010094738A1 (en) 2010-08-26

Similar Documents

Publication Publication Date Title
CO6491060A2 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES
UY33183A (en) INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT
ECSP099750A (en) IMIDAZOQUINOLINAS WITH IMMUNOMODULATING PROPERTIES
CR20140032A (en) TETRAHYDROPIRIDO-PIRIDINA AND TETRAHIDROPIRIDO-PIRIMIDINA COMPOUNDS AND THEIR USE AS MODULAR RECEPTORS OF C5A
UY32315A (en) PIPERIDINE COMPOUNDS AND USES OF THE SAME-596
UY32462A (en) NEW BIFENYLL DERIVATIVES FOR HEPATITIS C 644 VIRUS INFECTION TREATMENT
UY32158A (en) HETEROCICLIC DERIVATIVES AND METHODS OF USE OF THE SAME
UY33775A (en) MACROCYCLIC INHIBITORS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND THEIR USES
CR20110680A (en) HETEROCICLIC SULFONAMIDS, USES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
ECSP14013199A (en) COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF THE RESPIRATORY SINCICIAL VIRUS DISEASE
CR20160291A (en) CORTISTATINE AND SYNTHESIS ANALOGS AND USES OF THE SAME
CO6480932A2 (en) ANTAGONISTS OF THE HEDGEHOG TRAJECTORY OF DISTTITUTED FTALAZINA.
UY33536A (en) BICYCLIC INHIBITORS OF ACETIL-CoA-CARBOXYLASE AND USES OF THE SAME
UY32793A (en) INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS AND ITS USES
CR11641A (en) UREA HETEROCICLICAL DERIVATIVES AND METHODS OF USE OF THE SAME-211
UY32816A (en) PHARMACEUTICAL FORMULATION BASED ON 1- [2- (2,1,3-BENZOTIADIAZOL-5-ILAMINO) -6 (2,6-DICLOROFENIL) -PIRIDO [2,3-D] PIRIMIDIN-7-IL] -3- TERT-BUTIL-URÉA
ECSP12012103A (en) VIRUS FLAVIVIRIDAE INHIBITORS.
EA201270540A1 (en) MACROCYCLIC INHIBITORS INTEGRASES
CR10492A (en) NEW HETEROCICLICAL COMPOUNDS
CO6781541A2 (en) Glycoside derivatives and uses thereof
UY31885A (en) DERIVED FROM THE 1, 3, 5-TRIAZINA-2, 4-DIAMINAS-6-SUBSTITUTED-N-SUBSTITUTED AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS AND APPLICATIONS.
UY31141A1 (en) PIPERIDINE COMPOUNDS AND ITS USES
UY30544A1 (en) PIRROLO-PIPERIDINE COMPOUNDS AND PHARMACEUTICAL SALTS ACCEPTABLE OF THE SAME, MANUFACTURING PROCESSES, COMPOSITIONS AND APPLICATIONS
UY30856A1 (en) NEW DERIVATIVES OF 2,4 DIANILINOPIRIMIDINAS, ITS PREPARATION, AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND MAINLY AS IKK INHIBITORS
UY32674A (en) UREA HETEROCICLICAL DERIVATIVES AND THEIR EMPLOYMENT METHODS

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20110812